Why Is Ocular Therapeutix (OCUL) Stock Up Premarket Today? Sanofi Bid Rejection Fuels Rally
Ocular Therapeutix stock jumped over 18% in premarket trading after rejecting Sanofi’s $16 per share buyout offer, as investors turned bullish on the company’s late-stage pipeline.

























